About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 1470 record(s)
Req # A-2022-001085
Adverse Drug Reactions (ADRs) for ABILIFY. Report numbers: E2B_05661177, E2B_05661570, E2B_05662399, E2B_05664345, E2B_05664346, E2B_05664351, E2B_05664434, E2B_05664436, E2B_05664944, E2B_05644635.Organization: Health Canada
January 2023
Req # A-2022-001087
Adverse Drug Reactions (ADRs) for ABILIFY MAINTENA. Report numbers: E2B_05665045, E2B_05665144, E2B_05686891, E2B_05693250, E2B_05695992, E2B_05703028, E2B_05711493.Organization: Health Canada
January 2023
Req # A-2022-001129
Adverse Drug Reactions (ADRs). Report Number: 001010101.Organization: Health Canada
January 2023
Req # A-2022-001210
Adverse Drug Reaction (ADR). Report number: 000992869.Organization: Health Canada
January 2023
Req # A-2022-001216
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-111671-372.Organization: Health Canada
January 2023
Req # A-2022-001239
Adverse Drug Reaction (ADR) for DIPHENHYDRAMINE HCI. Report number: 001012008.Organization: Health Canada
January 2023
Req # A-2022-001241
Adverse Drug Reaction (ADR). Report number: E2B_05797534.Organization: Health Canada
January 2023
Req # A-2022-001259
Adverse Drug Reaction (ADR). Report number: 001010083.Organization: Health Canada
January 2023
Req # A-2022-001278
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-111869-805.Organization: Health Canada
January 2023
Req # A-2022-001294
Adverse Drug Reactions (ADRs) for VEKLURY. Report numbers: 001009551, 001011502.Organization: Health Canada
January 2023